Dr. Jose Luis García Giménez

Principal Investigator
Research Group on Epigenomics and Translational Epigenetics

Presentation

El Dr. José Luis García Giménez, es investigador post-doctoral del CIBER-ISCIII. Su investigación está dirigida a la comprensión e identificación de mecanismos epigenéticos que producen la variabilidad fenotípica en distintas enfermedades humanas.

Ha publicado más de 80 artículos en el campo del estrés oxidativo, las enfermedades raras y los biomarcadores epigéneticos. Es inventor de cuatro familias de patentes con extensión internacional estando una de ellas transferida a la industria.

El Dr. José Luis García Giménez fue fundador de EpiDisease S.L. la primera Spin-Off del CIBER y del ISCIII que desarrolla y comercializa test de diagnóstico IVD basados en biomarcadores epigenéticos.

Dr. Jose Luis García Giménez
Principal
Investigator
Dr. Jose Luis García Giménez

j.luis.garcia@uv.es

Publications
Age-Related microRNA overexpression in Lafora disease male mice provides links between neuroinflammation and oxidative stress. Roma-Mateo C, Lorente-Pozo S, Marquez-Thibaut L, Moreno-Estelles M, Garces C, Gonzalez D, Lahuerta M, Aguado C, Garcia-Gimenez JL, Sanz P, Pallardo FV. International Journal of Molecular Sciences. 2023 Jan 6;24(2):1089. doi: 10.3390/ijms24021089. PMID: 36674605

Oxidative stress and epigenetics: miRNA involvement in rare autoimmune diseases. Ibanez-Cabellos J, Pallardo F, Garcia-Gimenez J, Seco-Cervera M. Antioxidants. 2023 Mar 25;12(4):800. doi: 10.3390/antiox12040800. PMID: 37107175

The intricate role of non-coding RNAs in sepsis-associated disseminated intravascular coagulation. Canovas Cervera I, Nacher Sendra E, Osca Verdegal R, Dolz Andres E, Beltran Garcia J, Rodriguez Gimillo M, Ferrando Sanchez C, Carbonell N, Garcia Gimenez JL. International Journal of Molecular Sciences. 2023 Jan 30;24(3):2582. doi: 10.3390/ijms24032582. PMID: 36768905

Validation of circulating histone detection by mass spectrometry for early diagnosis, prognosis, and management of critically ill septic patients. Garcia-Gimenez J, Garcia-Lopez E, Mena-Molla S, Beltran-Garcia J, Osca-Verdegal R, Nacher-Sendra E, Aguado-Velasco C, Casabo-Valles G, Roma-Mateo C, Rodriguez-Gimillo M, Antunez O, Ferreres J, Pallardo F, Carbonell N. Journal of Translational Medicine. 2023 May 23;21(1):344. doi: 10.1186/s12967-023-04197-1. PMID: 37221624

Characterization of Early Peripheral Immune Responses in Patients with Sepsis and Septic Shock. Beltran-Garcia J, Osca-Verdegal R, Javega B, Herrera G, O’Connor J, Garcia-Lopez E, Casabo-Valles G, Rodriguez-Gimillo M, Ferreres J, Carbonell N, Pallardo F, Garcia-Gimenez J. Biomedicines. 2022 Feb 23;10(3):525. doi: 10.3390/biomedicines10030525. PMID: 35327327

CIBERER: Spanish national network for research on rare diseases: a highly productive collaborative initiative. Luque J, Mendes I, Gomez B, Morte B, de Heredia M, Herreras E, Corrochano V, Bueren J, Gallano P, Artuch R, Fillat C, Perez-Jurado L, Montoliu L, Carracedo A, Millan J, Webb S, Palau F, Lapunzina P, Pallardo Calatayud F, CIBERER Network. Clinical Genetics. 2022 May;101(5-6):481-493. doi: 10.1111/cge.14113. PMID: 35060122

Clinical and immunological aspects of microRNAs in neonatal sepsis. Fatmi A, Chabni N, Cernada M, Vento M, Gonzalez-Lopez M, Aribi M, Pallardo FV, Garcia-Gimenez JL. Biomedicine & Pharmacotherapy. 2021 Nov 19;145:112444. doi: 10.1016/j.biopha.2021.112444. PMID: 34808550

Extracellular histones activate endothelial NLRP3 inflammasome and are associated with a severe sepsis phenotype. Beltrán-García J, Osca-Verdegal R, Pérez-Cremades D, Novella S, Hermenegildo C, Pallardó FV, García-Giménez JL. Journal of Inflammation Research. 2022 Jul 25;15:4217-4238. doi: 10.2147/JIR.S363693. PMID: 35915852

Extracellular histones trigger oxidative stress-dependent induction of the NF-kB/CAM pathway via TLR4 in endothelial cells. Perez-Cremades D, Bueno-Beti C, Garcia-Gimenez J, Ibanez-Cabellos J, Pallardo F, Hermenegildo C, Novella S. Journal of Physiology and Biochemistry. 2022 Dec 5. doi: 10.1007/s13105-022-00935-z. PMID: 36464762

Histone citrullination mediates a protective role in endothelium and modulates inflammation. Osca-Verdegal R, Beltran-Garcia J, Paes A, Nacher-Sendra E, Novella S, Hermenegildo C, Carbonell N, Garcia-Gimenez J, Pallardo F. Cells. 2022 Dec 15;11(24):4070. doi: 10.3390/cells11244070. PMID: 36552833

Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies. Garcia-Gimenez JL, Garcia-Trevijano ER, Aviles-Alia AI, Ibanez-Cabellos JS, Bovea-Marco M, Bas T, Pallardo FV, Vina JR, Zaragoza R. Orphanet Journal of Rare Diseases. 2022 Dec 27;17(1):450. doi: 10.1186/s13023-022-02603-3. PMID: 36575500

Long non-coding RNAs as epigenetic regulators of immune checkpoints in cancer immunity. Saadi W, Fatmi A, Pallardo FV, Garcia-Gimenez JL, Mena-Molla S. Cancers. 2022 Dec 28;15(1):184. doi: 10.3390/cancers15010184. PMID: 36612180

MicroRNA-185-5p: a marker of brain-sparing in foetuses with late-onset growth restriction. Morales-Rosello J, Loscalzo G, Garcia-Lopez EM, Ibanez Cabellos JS, Garcia-Gimenez JL, Canada Martinez AJ, Perales Marin A. Epigenetics. 2022 Nov;17(11):1345-1356. doi: 10.1080/15592294.2021.2023271. PMID: 34969362

Neurodevelopmental outcome and epigenetic changes at 2 years associated with the oxygen load received upon postnatal stabilization: a pilot study. Lorente-Pozo S, Boronat N, Parra-Llorca A, Lara-Canton I, Solaz-Garcia A, Soler J, Buso E, Casabo-Valles G, Garcia-Gimenez J, Pallardo F, Vento M. Neonatology. 2022;119(5):575-584. doi: 10.1159/000525305. PMID: 35760056

The endothelial glycocalyx and neonatal sepsis. Fatmi A, Saadi W, Beltran-Garcia J, Garcia-Gimenez JL, Pallardo FV. International Journal of Molecular Sciences. 2022 Dec 26;24(1):364. doi: 10.3390/ijms24010364. PMID: 36613805

The genetic diversity and dysfunctionality of catalase associated with a worse outcome in Crohn’s Disease. Iborra M, Moret I, Buso E, Garcia-Gimenez J, Ricart E, Gisbert J, Cabre E, Esteve M, Marquez-Mosquera L, Garcia-Planella E, Guardiola J, Pallardo F, Serena C, Algaba-Chueca F, Domenech E, Nos P, Beltran B. International Journal of Molecular Sciences. 2022 Dec 14;23(24):15881. doi: 10.3390/ijms232415881. PMID: 36555526

Use of circular RNAs in diagnosis, prognosis and therapeutics of renal cell carcinoma. Osca Verdegal R, Beltran Garcia J, Gorriz J, Jabaloyas J, Pallardo F, Garcia Gimenez J. Frontiers in Cell and Developmental Biology. 2022 Jun 22;10:879814. doi: 10.3389/fcell.2022.879814. PMID: 35813211

Comparative analysis of chromatin-delivered biomarkers in the monitoring of sepsis and septic shock: a pilot study. Beltran-Garcia J, Manclus J, Garcia-Lopez E, Carbonell N, Ferreres J, Rodriguez-Gimillo M, Garces C, Pallardo F, Garcia-Gimenez J, Montoya A, Roma-Mateo C. International Journal of Molecular Sciences. 2021 Sep 14;22(18):9935. doi: 10.3390/ijms22189935. PMID: 34576097

DNA Methylation Analysis to Unravel Altered Genetic Pathways Underlying Early Onset and Late Onset Neonatal Sepsis. A Pilot Study. Lorente-Pozo S, Navarrete P, Garzón MJ, Lara-Cantón I, Beltrán-García J, Osca-Verdegal R, Mena-Mollá S, García-López E, Vento M, Pallardó FV, García-Giménez JL. Frontiers in Immunology. 2021 Feb 15;12:622599. doi: 10.3389/fimmu.2021.622599. PMID: 33659006

Implementing Precision Medicine in Human Frailty through Epigenetic Biomarkers. Garcia-Gimenez J, Mena-Molla S, Tarazona-Santabalbina F, Vina J, Gomez-Cabrera M, Pallardo F. International Journal of Environmental Research and Public Health. 2021 Feb 15;18(4):1883. doi: 10.3390/ijerph18041883. PMID: 33672064

Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved. Loscalzo G, Scheel J, Ibañez-Cabellos JS, García-Lopez E, Gupta S, García-Gimenez JL, Mena-Mollá S, Perales-Marín A, Morales-Roselló J. International Journal of Molecular Sciences. 2021 Dec 28;23(1):293. doi: 10.3390/ijms23010293. PMID: 35008715

Oxidative stress and rare diseases: from molecular crossroads to therapeutic avenues. Roma-Mateo C, Garcia-Gimenez J. Antioxidants. 2021 Apr 16;10(4):617. doi: 10.3390/antiox10040617. PMID: 33923815

Role of microRNAs as biomarkers in sepsis-associated encephalopathy. Osca-Verdegal R, Beltran-Garcia J, Pallardo FV, Garcia-Gimenez JL. Molecular Neurobiology. 2021 Sep;58(9):4682-4693. doi: 10.1007/s12035-021-02445-3. PMID: 34160774

Role of non-coding RNAs as biomarkers of deleterious cardiovascular effects in sepsis. Beltran Garcia J, Osca Verdegal R, Nacher Sendra E, Cardona Monzonis A, Sanchis Gomar F, Carbonell N, Pallardo FV, Lavie CJ, Garcia Gimenez JL. Progress in Cardiovascular Diseases. 2021;68:70-77. doi: 10.1016/j.pcad.2021.07.005. PMID: 34265333

Acute depletion of telomerase components DKC1 and NOP10 induces oxidative stress and disrupts ribosomal biogenesis via NPM1 and activation of the P53 pathway. Ibañez Cabellos S, Seco Cervera M, Picher Latorre C, Pérez Machado G, Garcia Gimenez J, Pallardo Calatayud F. Biochimica Et Biophysica Acta-Molecular. Cell Research. 2020 Dec;1867(12):118845. doi: 10.1016/j.bbamcr.2020.118845. PMID: 32910990

Circular RNAs in Sepsis: Biogenesis, Function, and Clinical Significance. Beltrán García J, Osca Verdegal R, Nacher-Sendra E, Pallardo Calatayud F, Garcia Gimenez J. Cells. 2020 Jun 25;9(6):1544. doi: 10.3390/cells9061544. PMID: 32630422

Circulating miRNA expression analysis reveals new potential biomarkers for human cutaneous melanoma staging. Sanchez Sendra B, Garcia Gimenez J, González Muñoz J, Navarro Cerveró L, Murgui A, Terradez Mas L, Pinazo Canales M, Martin Hernandez J, Monteagudo Castro C. Journal of the European Academy of Dermatology and Venereology. 2020 Mar;34(3):e126-e129. doi: 10.1111/jdv.16060. PMID: 31710393

Cofilin dysregulation alters actin turnover in frataxin-deficient neurons. Muñoz Lasso D, Molla B, Calap Quintana P, Garcia Gimenez J, Pallardo Calatayud F, Palau F, González Cabo P. Scientific Reports. 2020 Mar 23;10(1):5207. doi: 10.1038/s41598-020-62050-7. PMID: 32251310

Correction to: miRNA-23b as a biomarker of culture-positive neonatal sepsis. Fatmi A, Rebiahi S, Chabni N, Zerrouki H, Azzaoui H, Elhabiri Y, Benmansour S, Ibanez-Cabellos J, Smahi M, Aribi M, Garcia-Gimenez J, Pallardo F. Molecular Medicine. 2020 Dec 14;26(1):129. doi: 10.1186/s10020-020-00257-0. PMID: 33317443

Epigenetic biomarkers for human sepsis and septic shock: insights from immunosuppression. Beltrán García J, Osca-Verdegal R, Roma Mateo C, Carbonell Monleon N, Ferreres Franco J, Rodriguez M, Mulet Mascarell S, Garcia-Lopez E, Pallardo Calatayud F, Garcia Gimenez J. Epigenomics. 2020 Apr;12(7):617-646. doi: 10.2217/epi-2019-0329. PMID: 32396480

From genetics to epigenetics to unravel the etiology of adolescent idiopathic scoliosis. Perez-Machado G, Berenguer-Pascual E, Bovea-Marco M, Rubio-Belmar P, Garcia-Lopez E, Garzon M, Mena Molla S, Pallardo Calatayud F, Bas T, Viña Ribes J, Garcia Gimenez J. Bone. 2020 Nov;140:115563. doi: 10.1016/j.bone.2020.115563. PMID: 32768685

Impact of periodontal treatment on the RANKL/OPG ratio in crevicular fluid. López Roldán A, Garcia Gimenez J, Alpiste Illueca F. PLoS One. 2020 Jan 27;15(1):e0227757. doi: 10.1371/journal.pone.0227757. PMID: 31986169

MicroRNA-148b-3p and MicroRNA-25-3p Are Overexpressed in Fetuses with Late-Onset Fetal Growth Restriction. Morales-Rosello J, Garcia Gimenez J, Martinez Priego L, Gonzalez-Rodriguez D, Mena Molla S, Maquieira Catala A, Loscalzo G, Buongiorno S, Jakaite V, Canada Martinez A, Perales Marin A. Fetal Diagnosis and Therapy. 2020;47(9):665-674. doi: 10.1159/000507619. PMID: 32585676

miRNA-23b as a biomarker of culture-positive neonatal sepsis. Fatmi A, Rebiahi S, Chabni N, Zerrouki H, Azzaoui H, Elhabiri Y, Benmassour S, Ibañez Cabellos S, Smahi M, Aribi M, Garcia Gimenez J, Pallardo Calatayud F. Molecular medicine. 2020 Oct 8;26(1):94. doi: 10.1186/s10020-020-00217-8. PMID: 33032520

Non-coding RNAs and Coronary Artery Disease. Cardona-Monzonis A, Garcia Gimenez J, Mena Molla S, Pareja Galeano H, De La Guia-Galipienso F, Lippi G, Pallardo Calatayud F, Sanchis Gomar F. Advances in Experimental Medicine and Biology. 2020;1229:273-285. doi: 10.1007/978-981-15-1671-9_16. PMID: 32285418

Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Beltrán García J, Osca Verdegal R, Pallardo Calatayud F, Ferreres Franco J, Rodríguez González M, Mulet Mascarell S, Sanchis Gomar F, Carbonell Monleon N, Garcia Gimenez J. Antioxidants (Basel, Switzerland). 2020 Sep 29;9(10):936. doi: 10.3390/antiox9100936. PMID: 33003552

Oxygen in the neonatal period: Oxidative stress, oxygen load and epigenetic changes. Lorente-Pozo S, Parra-Llorca A, Lara-Canton I, Solaz A, Garcia Gimenez J, Pallardo Calatayud F, Vento M. Seminars in Fetal & Neonatal Medicine. 2020 Apr;25(2):101090. doi: 10.1016/j.siny.2020.101090. PMID: 32014366

Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age. Lahuerta M, Gonzalez D, Aguado C, Fathinajafabadi A, Garcia Gimenez J, Moreno-Estelles M, Roma Mateo C, Knecht E, Pallardo Calatayud F, Sanz P. Molecular Neurobiology. 2020 Mar;57(3):1607-1621. doi: 10.1007/s12035-019-01842-z. PMID: 31808062

Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches. Beltrán García J, Osca Verdegal R, Pallardo Calatayud F, Ferreres Franco J, Rodríguez González M, Mulet Mascarell S, Ferrando Sánchez C, Carbonell Monleon N, Garcia Gimenez J. Critical Care Medicine. 2020 Aug 18;10.1097/CCM.0000000000004625. doi: 10.1097/CCM.0000000000004625. PMID: 32826431

Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich’s Ataxia. Seco-Cervera M, Gonzalez-Cabo P, Pallardo F, Roma-Mateo C, Garcia-Gimenez J. Antioxidants. 2020 Dec 10;9(12):E1257. doi: 10.3390/antiox9121257. PMID: 33321938

Projects
Reference: CPP2021-008643
Title: Identificación y validación de biomarcadores mediante el uso de las ómicas y la Inteligencia Artificial para el diagnóstico temprano y mejora del manejo clínico de la sepsis
Funding body: Ministerio de Ciencia e Innovación
Principal Investigator: Edurne Carbonell
Duration: 2022 – 2024
Total budget: 150.269 €
Reference: DTS21/00193
Title: Test basados en péptidos spike-in y espectrometría de masas para la cuantificación de histonas circulantes y proteína APC, para el manejo clínico del paciente crítico
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Jose Luis García Giménez
Duration: 2022 – 2023
Total budget: 122.100 €
Reference: FIPSE 3819-21
Title: Valorización e internacionalización de HistShock, un test IVD para el diagnóstico y pronóstico de la sepsis y el shock séptico
Funding body: Fundación para la Innovación y Prospectiva en Salud en España (FIPSE)
Principal Investigator: José Luis García Giménez
Duration: 2021 – 2021
Total budget: 30.000 €
Reference: INNVA1/2020/85
Title: Valorización, estrategia de protección y transferencia de un método de diagnóstico y pronóstico de la sepsis y el shock séptico
Funding body: Agencia Valenciana de la Innovación-AVI Generalitat Valenciana
Principal Investigator: Jose Luis García Giménez
Duration: 2020 – 2021
Total budget: 110.670 €
Reference: PI19/00994
Title: Biomarcadores epigenéticos en sepsis y su implicación en inmunosupresión y futuras comorbilidades en supervivientes
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: José Luis García Giménez
Duration: 2020 – 2022
Total budget: 111.320 €
Reference: INNTA2/2020/4
Title: Incorporación de investigadores y tecnólogos para proyectos de innovación en empresas
Funding body: Agencia Valenciana de Innovación (AVI)
Principal Investigator: José Luis García Giménez
Duration: 2020 – 2021
Total budget: 33.013 €
Reference: ACCI-2018
Title: Validación de biomarcadores para el diagnóstico y el pronóstico de la sepsis neonatal
Funding body: CIBER de Enfermedades Raras (CIBERER-ISCIII)
Principal Investigator: José Luis García Giménez
Duration: 2019 – 2020
Total budget: 49.500 €
Reference: PI16/01036
Title: Epigenética e inmunosupresión. Uso de las histonas circulantes y sus modificaciones posttraduccionales como biomarcadores de diagnóstico y pronóstico en sepsis y shock séptico
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: José Luis García Giménez
Duration: 2017 – 2019
Total budget: 87.725 €
+ Info
Title: Potencial uso de la tecnología basada en microARNs para el diagnóstico y pronóstico de la escoliosis idiopática del adolescente
Doctoral candidate: Berenguer Pascual, Ester
Director(s): García Giménez, José Luis; Pérez Machado, Giselle; Mena Mollá Salvador
Date of the defense: 10/02/2022
University: Universitat de València

Title: Uso de las histonas circulantes y sus modificaciones post-traduccionales como biomarcadores en sepsis y shock séptico
Doctoral candidate: Beltrán García, Jesús
Director(s): García Giménez, José Luis; Pallardó Calatayud, Federico
Date of the defense: 20/01/2022
University: Universitat de València

Title: Influencia de factores epigeneticos en el desarrollo de la escoliosis idiopatica del adolescente
Doctoral candidate: Rubio Belmar, Pedro Antonio
Director(s): Bas Hermida, Teresa; García Giménez, José Luis
Date of the defense: 27/05/2021
University: Universitat de València

Title: Búsqueda de MIARNS en fluido crevicular gingival: expresión diferencial en sujetos con periodontitis crónica avanzada
Doctoral candidate: Almiñana Pastor, Pedro José
Director(s): García Giménez, José Luis; Bagán Sebastián, Jose Vicente; López Roldán, Andrés
Date of the defense: 04/03/2021
University: Universitat de València